Thompson Siegel & Walmsley’s HCA Healthcare HCA Stock Holding History

Thompson Siegel & Walmsley’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.61M	Hold	11,820	–	–	0.08%	239
2026 Q1	$5.59M	Sell	11,820 -1,000	-8%	-$503K	0.1%	204
2025 Q4	$5.99M	Sell	12,820 -628	-5%	-$292K	0.1%	200
2025 Q3	$5.73M	Sell	13,448 -4,600	-25%	-$1.78M	0.09%	207
2025 Q2	$6.91M	Sell	18,048 -200	-1%	-$72.1K	0.12%	168
2025 Q1	$6.31M	Sell	18,248 -1,280	-7%	-$412K	0.11%	162
2024 Q4	$5.86M	Buy	19,528 +3,500	+22%	+$1.22M	0.09%	180
2024 Q3	$6.51M	Buy	16,028 +800	+5%	+$293K	0.1%	174
2024 Q2	$4.89M	Sell	15,228 -2,172	-12%	-$706K	0.08%	192
2024 Q1	$5.8M	Buy	17,400 +500	+3%	+$153K	0.09%	186
2023 Q4	$4.57M	Hold	16,900	–	–	0.07%	202
2023 Q3	$4.16M	Buy	16,900 +9,600	+132%	+$2.63M	0.07%	204
2023 Q2	$2.21M	Sell	7,300 -1,000	-12%	-$278K	0.04%	227
2023 Q1	$2.19M	Sell	8,300 -1,205	-13%	-$306K	0.04%	225
2022 Q4	$2.28M	Buy	9,505 +9,500	+190,000%	+$2.13M	0.04%	217
2022 Q3	$1K	Hold	5	–	–	﹤0.01%	541
2022 Q2	$1K	Hold	5	–	–	﹤0.01%	546
2022 Q1	$1K	Hold	5	–	–	﹤0.01%	610
2021 Q4	$1K	Hold	5	–	–	﹤0.01%	627
2021 Q3	$1K	Sell	5 -42	-89%	-$10.3K	﹤0.01%	696
2021 Q2	$10K	Buy	47 +42	+840%	+$8.56K	﹤0.01%	648
2021 Q1	$1K	Sell	5 -145	-97%	-$25.6K	﹤0.01%	705
2020 Q4	$25K	Buy	+150	New	+$21.9K	﹤0.01%	522
2020 Q2	–	Sell	-125	Closed	-$11K	–	673
2020 Q1	$11K	Hold	125	–	–	﹤0.01%	543
2019 Q4	$18K	Hold	125	–	–	﹤0.01%	590
2019 Q3	$15K	Hold	125	–	–	﹤0.01%	603
2019 Q2	$17K	Hold	125	–	–	﹤0.01%	598
2019 Q1	$16K	Hold	125	–	–	﹤0.01%	565
2018 Q4	$16K	Hold	125	–	–	﹤0.01%	595
2018 Q3	$17K	Hold	125	–	–	﹤0.01%	622
2018 Q2	$13K	Hold	125	–	–	﹤0.01%	672
2018 Q1	$12K	Sell	125 -25	-17%	-$2.43K	﹤0.01%	672
2017 Q4	$13K	Sell	150 -402	-73%	-$32.3K	﹤0.01%	691
2017 Q3	$44K	Sell	552 -688	-55%	-$55.3K	﹤0.01%	541
2017 Q2	$108K	Sell	1,240 -105	-8%	-$8.88K	﹤0.01%	465
2017 Q1	$120K	Sell	1,345 -18,765	-93%	-$1.56M	﹤0.01%	486
2016 Q4	$1.49M	Buy	+20,110	New	+$1.51M	0.02%	280
2014 Q4	–	Sell	-9,350	Closed	-$659K	–	704
2014 Q3	$659K	Sell	9,350 -2,000	-18%	-$132K	0.01%	300
2014 Q2	$640K	Sell	11,350 -3,200	-22%	-$169K	0.01%	303
2014 Q1	$764K	Buy	+14,550	New	+$724K	0.02%	297

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Thompson Siegel & Walmsley's HCA Position: Q2 2026 in Review

Thompson Siegel & Walmsley held its HCA Healthcare (HCA) position steady in Q2 2026 at 11,820 shares worth $4.61M. The position accounts for 0.08% of the portfolio, ranked #239.

Thompson Siegel & Walmsley first reported a position in HCA in Q1 2014 and has held it in 40 quarters since. The position peaked at $6.91M in Q2 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Thompson Siegel & Walmsley held 11,820 shares of HCA Healthcare worth $4.61M as of Q2 2026.
Thompson Siegel & Walmsley left its HCA Healthcare share count unchanged in Q2 2026.
HCA Healthcare made up 0.08% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #239 holding.
Thompson Siegel & Walmsley first reported a position in HCA Healthcare in Q1 2014 and has held it in 40 quarters since.
Thompson Siegel & Walmsley's HCA Healthcare position peaked at $6.91M in Q2 2025.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.